The invention provides 25-hydroxyvitamin D for use in the treatment of hyperparathyroidism by controlled release. The 25-hydroxyvitamin D is administered by intravenous delivery, especially in dosage amounts of from 1 to 100 µg per day. The 25-hydroxyvitamin D may be (a) 25-hydroxyvitamin D2 or (b) 25-hydroxyvitamin D3 or (c) a combination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3.
申请公布号
EP2762132(A1)
申请公布日期
2014.08.06
申请号
EP20140166756
申请日期
2008.04.25
申请人
CYTOCHROMA INC.;PROVENTIV THERAPEUTICS, LLC
发明人
BISHOP, CHARLES W;TABASH, SAMIR P;AGUDOAWU, SAMMY A;WHITE, JAY A;CRAWFORD, KEITH H;MESSNER, ERIC J;PETKOVICH, P. MARTIN